lck2023summer

If Javascript is turned off, turn it on. Purpose Impact Domains Drivers Open Search Open Profile Investors Careers Newsroom Contact Us JP EN Open Search Open Products Information Search Close JP EN Purpose Impact Domains Drivers Profile Investors Careers Newsroom Contact Us Using this Website Privacy Policy Site Map Products Information Close Purpose Purpose Impact Domains Drivers Profile Investors Newsroom Purpose Message from Top Management CSV Purpose Long-term Management Vision and Medium-Term Business Plan KIRIN’s HISTORY Corporate Governance Risk Management Value Creation Model About Kirin Group Impact The Origin and Progress of CSV Management CSV Management Management Issues for Sustainable Growth (Group Materiality Matrix) A Responsible Alcohol Producer Health and Well-Being Community Engagement 　Respect for human rights The Environment Other material agenda and governance Domains Product brands Food & Beverages Health Science Pharmaceuticals Drivers Core technology that assures value creation Consumer centric marketing ICT accelerating value creation Diversity and inclusion, culture for innovation Financial strategy Profile Corporate Policy Corporate Overview Management Group Companies Company History Our Approaches in Quality Investors Management Policy Chart Generator Financial Data Non-Financial Information Share-related Information IR Library Individual Investors IR Events Calendar IR website user guide Disclaimer FAQs Third-Party Evaluations Newsroom News Releases Media kit Media Contacts Long-term Management Vision and Medium-Term Business Plan Management Plan Releases and Presentations Value Creation Model Value Creation Story Corporate Governance Overview Management Structure Management, Leadership & Advisory Remuneration System for Executive Officers Risk Management Compliance Kirin Group Tax Policy CSV Management 2022-2024 CSV Commitments Establishment and Operation of the Group CSV Committee Group Sustainability Meetings on Specific Issues Stakeholder Engagement Endorsement and participation in external organizations and initiatives United Nations Global Compact Policies Social contribution activities Sustainable Finance Marketing Communication Policy(MCP) Health and Well-Being What is “Health & Well-being” in Kirin Group? Ensuring food safety and security Ensuring stable supply, safety and reliability as a pharmaceutical company Provide pharmaceuticals for Unmet Medical Needs Support for maintaining the immune system Ensuring occupational health and safety Support for the prevention of non-communicable diseases Implementation of health management Helping to improve the performance of brain function and prevent decline Improvement of access to nutrition Community Engagement Respect for human rights Sustainable development of communities in raw material production areas and business development regions Creating bonds and trust for people's well-being Enhancing the sustainability of food economy Sustainable supply chain Community Topics Respect for human rights Kirin Group Human Rights Policy Embedding the Kirin Group Human Rights Policy in practice Implementing Human Rights Due Diligence The Environment Sustainable use of biological resources Sustainable use of water resources Sustainable recycling of containers and packaging Overcoming climate change Kirin Group's Environmental Vision 2050 Message from Top Management Engagement Vision / Policies / Structure Environmental management and CSV Holistic Environmental Management Information Disclosure Based on the TCFD Framework, TNFD Framework Draft, etc. Our Holistic Approach Third-Party Evaluations of environment Environmental Topics A Responsible Alcohol Producer Dealing with alcohol-related problems Policy and System Food and Beverages Kirin Brewery Company, Limited Lion Pty Ltd Kirin Beverage Company, Limited Mercian Coca-Cola Beverages Northeast, Inc. Health Science domain Message from Senior Executive Officer of Health Science Strategy Kirin Holdings Company, Limited Kyowa Hakko Bio Co., Ltd. Koiwai Dairy Products Co., Ltd. Kirin Beverage Company, Limited Core technology that assures value creation Accelerating intellectual property activities that leverage technological capabilities for the business Diversity and inclusion, culture for innovation Strengthening the human capital capability Diversity Cultivating the organizational culture Corporate Policy Achieving "Joy brings us together" The Story Behind Kirin Beer Labels Corporate Overview Barrier-free route to Kirin Group Head Office Group Companies Kirin Brewery Company, Limited Kirin Beverage Company, Limited Mercian Corporation Company History 1885‐1949 1950‐1989 1990‐1999 2000‐2009 2010‐2019 2020‐ Our Approaches in Quality Quality management Ensuring Product Safety and Reliability in the Food & Beverages Domain Ensuring Product Safety and Reliability in the Health Science Domain Chart Generator Yearly Data Quarterly Data Management Policy Corporate Disclosure Policy Financial Data Message from the Chief Financial Officer Management Analysis Of Financial Position, Operating Results, And Cash Flows Business Segments Consolidated Balance Sheets Consolidated Statements of Income Statements of Cash Flows Non-Financial Information Message from Senior Executive Officer of CSV Strategy ESG Databook Guideline Content Index Share-related Information General Meetings of Shareholders Dividend Payments and Own-share Repurchase Stock Information Share Data Stock Quote Bonds and Rating Analyst Coverage Articles of Incorporation and Regulations Public Notice IR Library Financial Results（Financial Results/Presentations/Financial Statements） IR News Releases IR Events Releases and Presentations Archive Integrated Report Investor’s Guide Market data and Sales Kirin Group Environmental Report Management Plan Releases and Presentations Long-term (Archive) Medium-term (Archive) Current Fiscal Year (Archive) Management Structure Interview with Independent Non-executive Directors 2022-2024 CSV Commitments 2019-2021 CSV Commitments Social contribution activities The Pink Ribbon Activity JICA-KIRIN Fellowship Program Marketing Communication Policy(MCP) Guidelines of Product Labeling Respect for human rights Kirin Group Human Rights Policy Embedding the Kirin Group Human Rights Policy in practice Implementing Human Rights Due Diligence Sustainable development of communities in raw material production areas and business development regions Japanese hops Tea Leaves Vineyards Sustainable supply chain Policy on Sustainable Procurement Activities to Promote Sustainable Procurement Working Together with Suppliers Engagement Dialogue 01 Dialogue 02 Dialogue 03 Dialogue 04 Dialogue 05 Holistic Environmental Management Information Disclosure Based on the TCFD Framework, TNFD Framework Draft, etc. Risks and Opportunities Dealing with alcohol-related problems What is Slow Drinking? Other initiatives in Japan Business Segments Year Quarter Consolidated Balance Sheets Year Quarter Consolidated Statements of Income Year Quarter Statements of Cash Flows Year Quarter General Meetings of Shareholders Previous Fiscal Years Financial Results（Financial Results/Presentations/Financial Statements） Archive IR Events Releases and Presentations Archive KIRIN R＆D DAY 2020 Archive Integrated Report Integrated Report PDF Kirin Integrated Report 2023 Kirin Integrated Report 2022 Kirin Integrated Report 2021 KIRIN CSV REPORT 2020 KIRIN CSV REPORT 2019 KIRIN REPORT 2018 KIRIN REPORT 2016 KIRIN REPORT 2015 Annual Reports (Back numbers) Market data and Sales Domestic sale outline report(Monthly) Domestic Monthly sales report(Archive) Domestic Alcohol market data(Year) Beer consumption by region(Year) Beer consumption by country(Year) Domestic Soft drink market data(Year) Kirin Group Environmental Report Archive Kirin Group Human Rights Policy Feedback from stakeholders during the establishment of the 2018 Human Rights Policy Activities to Promote Sustainable Procurement Past Reports on human rights impact assessments of supply chains JICA-KIRIN Fellowship Program Greetings from the Host Institution Representatives Overview Fellow Introduction About United Nations University-Kirin Fellowship KIRIN CSV REPORT 2020 Message from Top Management Past and Present Special Feature: Growth Strategies for the Health Science Domain Strengthening Organizational Capabilities Financial and Non-financial Highlights Message from the Chief Financial Officer Interview with the Non-executive Director KIRIN CSV REPORT 2019 Message from Top Management Interview with the Chief Financial Officer Strengthening Our Non-Financial Assets CSV Stories CASE1 Pharmaceuticals business CSV Stories CASE2 Businesses bridging Pharmaceuticals and Food & Beverages CSV Stories CASE3 Community Engagement CSV Stories CASE4 The Environment CSV Stories CASE5 A Responsible Alcohol Producer Discussion with Management Interview with an Outside Director Financial and Non-financial Highlights Past and Present KIRIN REPORT 2018 Message from Top Management Discussion with Management, Part1 Discussion with Management, Part2 Interview with an Outside Director CASE1 Kirin Ichiban Shibori Relaunch and Craft Beer Market Development CASE2 Pharmaceuticals for Worldwide Markets CASE3 Lactococcus lactis strain Plasma Stars in New Products CASE4 Advanced High-Efficiency Facilities at Myanmar Brewery History of the Kirin Group The Kirin Group Today Overview by segment and business for fiscal 2017 Management's discussion & analysis Financial & Non-Financial Highlights KIRIN REPORT 2016 To Our Stakeholders Long-Term Management Vision and Medium-Term Business Plan CFO’s Message Overview of the Kirin Group’s Business Kirin’s Foundation for Value Creation Interview with an Outside Director KIRIN REPORT 2015 KEY POINTS ABOUT KIRIN Long-Term Management Vision and Medium-Term Business Plan KIRIN’S GROWTH STRATEGIES A Conversation between Outside Directors Management Issues for Sustainable Growth (Group Materiality Matrix) Technology (R&D) Foundation SCM Foundation Human Resources Foundation Fellow Introduction 2019 Fellow Researchers and Research Themes 2018 Fellow Researchers and Research Themes 2017 Fellow Researchers and Research Themes About United Nations University-Kirin Fellowship List of Former United Nations University-Kirin Fellows Special Feature: Growth Strategies for the Health Science Domain Strategic Decisions in 2019 / Message from the Officer in Charge of Health Business Strategy Part1 Interview with the Executive Officer of R&D Strategy Part2 Creating Synergies with FANCL Corporation Strengthening Organizational Capabilities Enhancing Kirin Beverage's marketing capabilities Development of our human resources Strengthening Our Non-Financial Assets Honkirin and our marketing reform R&D Strategy:Technology creating trusted value Human resources strategies:Diversity and inclusion, culture for innovation Financial & Non-Financial Highlights Financial Highlights Non-Financial Highlights To Our Stakeholders Kirin’s Management Environment,Vision, and Strategies Progress with the Medium-Term Business Plan Issues and Future Initiatives Aiming to Be a Company That Is Completely Trusted Long-Term Management Vision and Medium-Term Business Plan Long-Term Management Vision Medium-Term Business Plan Recognizing the Challenges and Future Initiatives Kirin’s Foundation for Value Creation The Kirin Group’s Value Creation Marketing Research & Development Supply Chain KEY POINTS ABOUT KIRIN Business Structure / Earnings Structure Kirin's History of Progress Long-Term Management Vision and Medium-Term Business Plan Long-Term Management Vision Medium-Term Business Plan List of Former United Nations University-Kirin Fellows 2016 Fellow's Research Projects 2015 Fellow's Research Projects 2014 Fellow's Research Projects 2013 Fellow's Research Projects 2012 Fellow's Research Projects 2011 Fellow's Research Projects 2010 Fellow's Research Projects 2009 Fellow's Research Projects Close [first sentense] Home Newsroom News Releases 2007 December 7, 2007 Notification with Respect to Results of Tender Offer for Shares of Kyowa Hakko Kogyo Co.,Ltd. Kirin Holdings Company, Limited (the "Company" or the "Tender Offeror") has concluded as of December 6, 2007 a tender offer (the "Tender Offer") for the shares of common stock of Kyowa Hakko Kogyo Co., Ltd (the "Target Company") (Code number:4151, the First Section of the Tokyo Stock Exchange) which commenced on October 31, 2007. In connection with the conclusion of the Tender Offer, we would like to provide notice of the following: 1. Description of the Tender Offer (1) Name and Location of Head Office of Tender Offeror Kirin Holdings Company, Limited 2-10-1 Shinkawa,Chuo-ku, Tokyo (2) Name of Target Company Kyowa Hakko Kogyo Co.,Ltd. (3) Class of Shares Purchased Common Stock (4) Number of Share Certificates to be Purchased in the Tender Offer Class of Shares Number Scheduled to be Purchased Represented by Shares Minimum Number Scheduled to be Purchased Represented by Shares Maximum Number Scheduled to be Purchased Represented by Shares Share Certificate 111,578,000 shares 79,849,000 shares 111,578,000 shares Certificate of Stock Acquisition Rights &＃8211; &＃8211; &＃8211; Bond Certificate with Stock Acquisition Rights &＃8211; &＃8211; &＃8211; Trust Beneficiary Certificates for Share Certificates &＃8211; &＃8211; &＃8211; Depositary Receipt for Share Certificates (       ) &＃8211; &＃8211; &＃8211; Total 111,578,000 shares 79,849,000 shares 111,578,000 shares (5) Period of the Tender Offer From Wednesday, October 31, 2007 through Thursday, December 6, 2007 (26 business days in Japan) (the "Tender Offer Period") (6) Purchase Price of the Tender Offer 1,500 yen per share of common stock 2. Result of the Tender Offer (1) Condition of Tendered Shares and other Securities Class of Shares Number Tendered Represented by Shares Number Purchased Represented by Shares Share Certificate 273,505,696 shares 111,578,000 shares Certificate of Stock Acquisition Rights &＃8211; &＃8211; Bond Certificate with Stock Acquisition Rights &＃8211; &＃8211; Trust Beneficiary Certificates for Share Certificates &＃8211; &＃8211; Depositary Receipt for Share Certificates (       ) &＃8211; &＃8211; Total 273,505,696 shares 111,578,000 shares (2) Success of the Tender Offer In the Tender Offer, a condition was imposed that if the total number of shares tendered in the Tender Offer was less than the minimum number of share certificates scheduled to be purchased represented by shares (79,849,000 shares), none of the tendered shares would be purchased by the Tender Offeror. Because the total number of shares tendered in the Tender Offer was more than the minimum number of share certificates to be purchased represented by shares, the condition was satisfied. Because the total number of shares tendered in the Tender Offer exceeded the maximum number scheduled to be purchased represented by shares (111,578,000 shares) the Tender Offeror will make delivery and other settlements with respect to the purchase of shares pursuant to the pro rata method as defined in Article 27-13, Item 5 of the Financial Instruments and Exchange Law (Law No. 25 of 1948 as amended) (the "Law") and Article 32 of the Cabinet Ordinance regarding disclosure of tender offer for shares and other securities by non-issuers (MOF Ordinance No. 38 of 1990 as amended) (the "TOB Order"). (3) Ownership Percentage of Share Certificates after the Tender Offer Category Number of Voting Rights Ownership Percentage of Share Certificates Number of Voting Rights Represented by Share Certificates Owned by the Tender Offeror before the Tender Offer 1 0.00% Number of Voting Rights Represented by Share Certificates Owned by the Tender Offeror after the Tender Offer 111,579 28.49% Number of Voting Rights Represented by Share Certificates Owned by Specially Related Parties before the Tender Offer 0 0% Number of Voting Rights Represented by Share Certificates Owned by Specially Related Parties after the Tender Offer 0 0% Total Number of Voting Rights of Shareholders of the Target Company 391,528 (Note 1) The "Total Number of Voting Rights of Shareholders of the Target Company"represents the number of voting rights of all of the shareholders as of the fiscal year ended March 31, 2007 as described in the 84th Annual Securities Report submitted by the Target Company to the Kanto Local Finance Bureau on June 20, 2007. However, for the purpose of calculating "Ownership Percentage of Share Certificates", the "Total Number of Voting Rights of Shareholders of the Target Company" is calculated to be 391,669 units. This number includes (i) the number of voting rights (61 units) represented by the number of shares of the Target Company delivered upon exercise of the stock acquisition rights in relation to the stock option plan prior to the last day of the Tender Offer Period (61,000 shares), and (ii) the number of voting rights (80 units)represented by the number of shares of the Target Company held by Japan Synthetic Alcohol Co., Ltd. (80,000 shares). (Note 2) "Ownership Percentage of Share Certificates" is rounded to the nearest hundredth of a percent. (4) Calculation for Purchase Pursuant to the Pro Rata Method Because the total number of shares tendered in this Tender Offer exceeded the maximum number scheduled to be purchased represented by shares (111,578,000 shares), as described in the "Notification with Respect to Commencement of Tender Offer for Shares of Kyowa Hakko Kogyo Co., Ltd." and the "Tender Offer Registration Statement", all or part of the excess portion will not be purchased and the Tender Offeror will make delivery and other settlements with respect to the purchase of shares pursuant to the pro rata method as defined in Article 27-13, Item 5 of the Law and Article 32 of the TOB Order. Because the total number of shares to be purchased from all tendering shareholders (the "Tendering Shareholders") was calculated pursuant to the pro rata method, in which shares constituting less than one unit were rounded off, and as a result was less than the maximum number scheduled to be purchased represented by shares, the Tender Offeror purchased one unit from each Tendering Shareholder in descending order, beginning with shareholders that owned the most rounded-off shares, until the total number of shares to be purchased was equal to the maximum number scheduled to be purchased represented by shares. (If by purchasing units, the Tender Offeror would have exceeded the number of shares tendered in the Tender Offer, the Tender Offeror purchased shares until the number of shares to be purchased was equal to the number of shares tendered.) However,because the result would have exceeded the maximum number scheduled to be purchased represented by shares if the Tender Offeror had purchased units from all Tendering Shareholders who hold equal numbers of shares that were rounded-up, the Tender Offeror selected by lottery who the Tender Offeror would purchase units from, to the extent that the total number of shares purchased was no less than the maximum number scheduled to be purchased represented by shares. (5) Funds Required for Tender Offer, etc. 167,367,000,000 yen (6) Method of Settlement Name and Address of Head Offices of Securities Companies and Banks, etc. in Charge of Settlement Nikko Citigroup Limited 1-5-1 Marunouchi, Chiyoda-Ku, Tokyo Nikko Cordial Securities Inc. 3-3-1 Marunouchi,Chiyoda-Ku, Tokyo Commencement Date of Settlement Thursday,December 13, 2007 Method of Settlement A notice of purchase will be mailed to the address or location of the Tendering Shareholder (or the standing proxy in the case of a non-resident shareholder) promptly after the end of the Tender Offer Period. Payment of the purchase price will be made in cash. Nikko Citigroup Limited (the "Tender Offer Agent") or Nikko Cordial Securities Inc. (the "Sub-Agent") will, in accordance with the shareholder's instructions, remit the purchase price for share certificates promptly after the commencement date of settlement to the account designated by the Tendering Shareholder (or the standing proxy in the case of a non-resident shareholder). (7) Method to return Share Certificates The Tender Offer Agent or the Sub-Agent will return all tendered share certificates which are required to be returned to the Tendering Shareholders promptly after the settlement date, Thursday, December 13, 2007, by the method described below. Please take this into consideration in the event of a sale, depositing your shares with a different broker, or other disposal of the shares to be returned conducted prior to the return of such shares. In cases where share certificates were submitted to the Tender Offer Agent or the Sub-Agent upon application, the share certificates which were not purchased shall be delivered to the Tendering Shareholder or mailed to the Tendering Shareholder's address (in the case of a non-resident shareholder, the address of their standing proxy). In cases where share certificates are kept in custody by the Tender Offer Agent or the Sub-Agent (or by the Japan Securities Depository Center through the Tender Offer Agent or the Sub-Agent) the share certificates which were not purchased will be returned to the same condition of custody as at the time of application. 3. Policies and Outlook After the Tender Offer After the Tender Offer is completed, to promptly implement the integration of the pharmaceutical business, the Target Company and Kirin Pharma Company Ltd ("Kirin Pharma") will, subject to approval being obtained at their respective general meetings of shareholders, conduct a share exchange (the "Share Exchange") effective as of April 1, 2008. As a result, Kirin Pharma will become a wholly owned subsidiary of the Target Company and the Tender Offeror shall become the parent company holding, in conjunction with the shares acquired through the Tender Offer and related transactions, shares equivalent to 50.10% of the standard number of shares (Note 1) of the Target Company. In the Share Exchange, 8,862 shares (Note 2) of common stock of the Target Company will be allocated and delivered for each share of common stock of Kirin Pharma, for a total of 177,240,000 shares. (Note 1) In this Notification, the standard number of shares (the "Standard Number of Shares") is the sum of (i)the total number of issued shares of common stock of the Target Company (including the number of treasury shares of common stock held by the Target Company) and (ii) any excess of the number of common stock underlying the stock acquisition rights issued by the Target Company, over the number of treasury shares of common stock held by the Target Company. (Note 2) Treasury shares of Kirin Pharma are scheduled to be cancelled by the day before the Share Exchange becomes effective. After the Share Exchange becomes effective, the Target Company as the surviving company (the "Surviving Company") and Kirin Pharma as the merging company will merge (the "Merger") with an effective date of October 1, 2008. As a result of the Merger, the integration of the pharmaceutical businesses of Kyowa Hakko and Kirin Pharma will be complete. Matters to be provided in the merger agreement with respect to the Merger (the "Merger Agreement"), other than the above, will be determined before the conclusion of the Merger Agreement. In accordance with the Merger, the trade name of the Surviving Company will change and, after approval from the general meeting of shareholders, the trade name of the Surviving Company after the Merger shall become "Kyowa Hakko Kirin Co., Ltd." After the Tender Offer and the Share Exchange, the President and Representative Director of the Target Company shall remain in the same position, for the time being. In addition, it was agreed in the integration agreement (the "Integration Agreement") that the Target Company shall,subject to the Share Exchange becoming effective, make changes to its management structure pursuant to the Integration Agreement including (i) seeking approval of agenda with respect to electing two persons appointed by the Tender Offeror as Directors of the Target Company at the Extraordinary Meeting of Shareholders of Kyowa Hakko, and (ii) electing one of the Directors appointed by the Tender Offeror as Vice President and Representative Director of the Target Company. Furthermore, it is agreed that, subject to the Share Exchange becoming effective, (i) Kirin Pharma shall elect one person whom the Target Company appoints as a Director of Kirin Pharma, and (ii) the Tender Offeror shall seek approval with respect to the election of the President and Representative Director of the Target Company as a Director of the Tender Offeror at the ordinary general meeting of shareholders for the fiscal year ending December 31, 2007. After the Tender Offer and the Share Exchange, the Target Company will become a consolidated subsidiary of the Tender Offeror which, as a pure holding company, will hold a majority of the shareholder voting rights of the Target Company. The Target Company will, while respecting the fundamental principles of the Kirin Group's operation, conduct an autonomous business activity based on independence and mobility, ensure the independence of its management as an ongoing public listed company, and continue to promote the maximization of profits for all of its shareholders and the sustained expansion of corporate value. Therefore, the shareholding ratio of the Tender Offeror in the Target Company (Note 2) shall be 50.10% in principle for a period of 10 years from the date of the execution of the Integration Agreement, and after the Integration, the Tender Offeror will cooperate in the strongest reasonable manner to maintain the listing of the shares of the Surviving Company established through the Merger. Furthermore, the Kirin Group agrees not to acquire any new shares/stock acquisition rights of the Target Company, or dispose (including sale or disposition as collateral) of shares/stock acquisition rights of the Target Company which the Kirin Group currently holds, for a period of 10 years from the date of the execution of the Integration Agreement, except as prescribed, without the consent of the Target Company. (Note 3) In this Notification,the shareholding ratio of the Tender Offeror in the Target Company shall be the sum of (i) the number of shares of common stock of the Target Company which the Tender Offeror (including its subsidiaries and affiliates but excluding the Target Company and their subsidiaries and affiliates) holds and (ii) the number of new shares of common stock of the Target Company which will be issued upon exercise of stock acquisition rights held by the Tender Offeror, divided by the Standard Number of Shares of the Target Company. 4. Location at which a Copy of the Tender Offer Report is available to the Public Head Office of Kirin Holdings Company, Limited (2-10-1 Shinkawa, Chuo-ku, Tokyo) Tokyo Stock Exchange Group, Inc. (2-1 Kabutocho, Nihonbashi, Chuo-ku, Tokyo) (Note 1) Except as otherwise provided in this Notification, a reference to a number of days or a date and time means such number of days or date and time in Japan. (Note 2) "Business days" in this Notification means a number of days excluding those days provided in Article 1(1) of the Government Holiday Law. (Note 3) Unless otherwise provided in this Notification, all procedures with respect to the Tender Offer shall be conducted in the Japanese language. If any part of the documents relating to the Tender Offer is prepared in English, and in the event that any inconsistency exists between the English and Japanese documents, the Japanese documents shall take priority over the English documents. (Note 4) This Notification contains forward-looking statements as defined under Section 27A of the U.S. Securities Act of 1933 and Section 21E of the U.S. Securities Exchange Act of 1934. As a result of known or unknown risks, uncertainty or other factors, actual results could differ materially from any explicit or implicit forecasts, among others, presented as forward-looking statements. No assurance is given by the Tender Offeror or any affiliates of the Tender Offeror that any such explicit or implicit forecasts, among others, presented as forward-looking statements will be achieved and actual results could differ materially.The forward-looking statements contained in this Notification were made based on the information available to the Tender Offeror as of the date of this Notification and, except where bound by law or Tokyo Stock Exchange regulations, the Tender Offeror and any affiliates of the Tender Offeror accept no obligation to change or revise the statements to reflect future events or circumstances. Integrated Report Share Please do not forward or share information about alcoholic beverages with anyone under the legal drinking age. Purpose Message from Top Management CSV Purpose Long-term Management Vision and Medium-Term Business Plan KIRIN’s HISTORY Corporate Governance Risk Management Value Creation Model Impact CSV management Management Issues for Sustainable Growth (Group Materiality Matrix) A Responsible Alcohol Producer Health and Well-Being Community Engagement The Environment Other material agenda and governance Domains Product brand Food & Beverages Health Science Pharmaceuticals Drivers Core technology that assures value creation Consumer centric marketing ICT accelerating value creation Diversity and inclusion, culture for innovation Financial Strategy Profile Investors Careers Newsroom Contact Us Terms and Conditions Privacy Policy Site Map You must be of legal drinking age to consume alcohol. Don't drink and drive. Enjoy responsibly. It is advisable not to drink alcohol during pregnancy and breastfeeding. Do not litter! Let's recycle after drinking! © 2007-2024 Kirin Holdings Company, Limited. TOP